Prevention and healing of experimental indomethacin-induced gastric lesions: Effects of ebrotidine, omeprazole and ranitidine

European Journal of Gastroenterology and Hepatology

Volumn 12, Issue 3, 2000, Pages 313-318

  Arroyo, María Teresa ^a   Lanas, Angel ^a   Sáinz, Ricardo ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Ebrotidine; Gastric secretion; Gastric ulcer; Healing; Indomethacin; Omeprazole; Prevention; Ranitidine

Indexed keywords

EBROTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; INDOMETACIN; OMEPRAZOLE; RANITIDINE; STOMACH SECRETION INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH SECRETION; STOMACH ULCER; ULCER HEALING;

EID: 0034028668     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200012030-00009     Document Type: Article

References (25)

1. 1 Barrier CH, Hirschowitz BI. Controversies in the detection and management of nonsteroidal antiinflammatory drug-induced side effects of the upper gastrointestinal tract. Arthritis Rheum 1989; 32:926-932.
2. 2 Kurata JH, Abbey DE. The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations. J Clin Gastroenterol 1990; 12:260-266.
3. 3 Yeomans ND, Tulassay Z, Juhasz L, Racz I, Howard J, Van Rensburg CJ, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998; 338:719-726.
4. 4 Silverstein F, Graham D, Senior J, Wyn H, Struthers B, Bittman R, Geis S. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. Ann Intern Med 1995; 123:241-249.
5. 5 Daneshmend TK, Stein AG, Bhaskar NK, Hawkey CJ. Abolition by omeprazole of aspirin-induced gastric mucosal injury in man. Gut 1990; 31:514-519.
6. 6 Lanas A, Haggerty P, Hirschowitz BI. Ingestion of aspirin prevents platelet-induced human fibroblasts growth - implications for peptic ulcer healing. Scand J Gastroenterol 1994; 29:17-22.
7. 7 Taha A, Hudson N, Hawkey C, Swannell A, Trye P, Cottrell J, et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med 1996; 334:1435-1439.
8. 2-receptor antagonist with local gastroprotective activity. Eur J Gastroenterol Hepatol1991; 3:941-947.
9. 9 Slomiany BL, Piotrowski J, Murty VLN, Slomiany A. Mechanism of ebrotidine protection against gastric mucosal injury induced by ethanol. Gen Pharmacol 1992; 23:719-727.
10. 2-receptor antagonist with mucosal strengthening activity. Biochem Int 1992; 26:659-667.
11. 11 Slomiany BL, Lopez RA, Liau YH, Slomiany A. Effect of ebrotidine on the synthesis and secretion of gastric sulfomucin. Gen Pharmacol 1993; 24:611-617.
12. 12 Slomiany BL. Piotrowski J, Czajkowski A, Yotsumoto F, Siomiany A. Gastric mucosal EGF and PDGF receptor expression with ulcer healing by ebrotidine. Am J Gastroenterol 1994; 89:894-897.
13. 13 Satoh H, Inada I, Hirata T, Maki Y. Indomethacin produces gastric antral ulcers in the refed rat. Gastroenterology 1981; 91:719-725.
14. 14 Schmassmann A, Tarnawski A, Peskar BM, Varga L, Flogerzi B, Halter F. Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin. Am J Physiol 1995; 268:G276-G285.
15. 15 Konturek P, Brzozowski T, Konturek S, Márquez M, Torres J, Ortiz J. Studies on the cytoprotective and antisecretory activity of ebrotidine. Arzneimittelforschung 1997; 47:578-589.
16. 16 Guglietta A, Hervada R, Nardi RV. Computer-based quantitative morphometric analysis of the dynamic characteristics of indomethacin and ethanol-induced gastric lesions in the rat. J Pharmacol Methods 1990; 24:73-78.
17. 17 Guglietta A, Hervada R, Nardi RV, Lesch CA. Effect of platelet-derived growth factor-BB on indomethacin-induced gastric lesions in rats. Scand J Gastroenterol 1992; 27:673-676.
18. 18 Konturek SJ, Kwiecien N, Sito E, Obtulowicz W, Kaminski K, Oleksy J. Effects of ebrotidine on aspirin-induced gastric mucosal damage and blood flow in humans. Scand J Gastroenterol 1993; 28:1047-1050.
19. 19 Redferrn JS, Feldman M. Role of endogenous prostaglandins in preventing gastrointestinal ulceration: induction of ulcers by antibodies to prostaglandins. Gastroenterology 1989; 96:596-605.
20. 20 Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979; 77:761-767.
21. 21 Yeomans ND, Skeljo MV. Repair and healing of established gastric mucosal injury. J Clin Gastroenterol 1991; 13(suppl 1):S37-S46.
22. 22 Inauen W, Wyss PA, Kayser S. Influence of prostaglandin, omeprazole, and indomethacin on healing of experimental gastric ulcer in the rat. Gastroenterology 1988; 95:636-641.
23. 23 Kollberg B, Isenberg JI, Johansson C. Oral omeprazole protects gastric mucosa against ethanol [Abstract]. Gastroenterology 1983; 84:1212A.
24. 24 Mattsson H, Andersson K, Larsson H. Omeprazole provides protection against experimentally induced gastric lesions. Eur J Pharmacol 1983; 91:111-114.
25. 25 Konturek SJ, Brzozowski T, Radecki T. Protective action of omeprazole, a benzimidazole derivate, on gastric mucosal damage by aspirin and ethanol in rats. Digestion 1983; 27:159-164.